Cargando…

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

Umbilical cord blood (CB) has emerged as an effective alternative donor source for hematopoietic stem cell transplantation. Despite this success, the prolonged duration of immune suppression following CB transplantation and the naiveté of CB T cells leave patients susceptible to viral infections. Ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dave, Hema, Luo, Min, Blaney, J.W., Patel, Shabnum, Barese, Cecilia, Cruz, Conrad Russell, Shpall, Elizabeth J., Bollard, Catherine M., Hanley, Patrick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415312/ https://www.ncbi.nlm.nih.gov/pubmed/28480300 http://dx.doi.org/10.1016/j.omtm.2017.02.001

Ejemplares similares

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients
por: Papadopoulou, Anastasia, et al.
Publicado: (2013)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
por: Papadopoulou, Anastasia, et al.
Publicado: (2021)

No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran
por: Dowran, Razieh, et al.
Publicado: (2019)

BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2018)

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation
por: Bae, Hyunjoo, et al.
Publicado: (2023)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients
por: Dasari, Vijayendra, et al.
Publicado: (2016)

BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients
por: Stervbo, Ulrik, et al.
Publicado: (2019)

The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
por: Xuying, Pei, et al.
Publicado: (2023)

Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
por: Gerdemann, Ulrike, et al.
Publicado: (2012)

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections
por: Vasileiou, Spyridoula, et al.
Publicado: (2020)

Clinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord
por: Furutate, Sakiko, et al.
Publicado: (2011)

Congenital and Postnatal CMV and EBV Acquisition in HIV-Infected Zimbabwean Infants
por: Gumbo, Hlanai, et al.
Publicado: (2014)

CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV–CMV–EBV Co-Infected Groups
por: Nazim, Fizza, et al.
Publicado: (2022)

IgM Positivity for Both EBV and CMV: A Clinical Conundrum
por: Jhaveri, Tulip A, et al.
Publicado: (2022)

The effect of BKV reactivation on cytokines behavior in kidney transplanted patients
por: Rahimi, Zahra, et al.
Publicado: (2022)

Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis
por: Wang, Xia, et al.
Publicado: (2010)

The prevalence of CMV and EBV among the patients with the colorectal cancer; a molecular approach
por: Arastefar, Amir, et al.
Publicado: (2015)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023)

Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future
por: Sanchez-Petitto, Gabriela, et al.
Publicado: (2023)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
por: Gerdemann, Ulrike, et al.
Publicado: (2011)

Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
por: Adjei, Andrew A, et al.
Publicado: (2008)

Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients
por: Rasmussen, NS, et al.
Publicado: (2015)

Hemophagocytic Lymphohistiocytosis in a Patient With Hodgkin lymphoma and Concurrent EBV, CMV, and Candida Infections
por: Mustafa Ali, Moaath, et al.
Publicado: (2017)

Age and CMV-Infection Jointly Affect the EBV-Specific CD8(+) T-Cell Repertoire
por: Lanfermeijer, Josien, et al.
Publicado: (2021)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
por: Pfeiffer, Thomas, et al.
Publicado: (2023)

EBV covers its tracks
por: Bashyam, Hema
Publicado: (2007)

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis
por: Valenzuela, Fernando, et al.
Publicado: (2015)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System
por: van Stijn, Diana, et al.
Publicado: (2021)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

The association between polyomavirus BK strains and BKV viruria in liver transplant recipients
por: Wang, Robert Y. L., et al.
Publicado: (2016)

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
por: Jiang, Wei, et al.
Publicado: (2022)

P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Yalcin, Koray, et al.
Publicado: (2023)

Functional Differences Between EBV- and CMV-Specific CD8(+) T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL
por: Hofland, Tom, et al.
Publicado: (2020)

On Prolapse of the Umbilical Cord
por: Wilson, J. G.
Publicado: (1866)

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
por: Janeczko, Małgorzata, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jd19sgv3aikuref314g00vl6kc